These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16757713)

  • 1. High-dose statins and the IDEAL study.
    Cayley WE
    JAMA; 2006 Jun; 295(21):2476; author reply 2478-9. PubMed ID: 16757713
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose statins and the IDEAL study.
    Ravnskov U; Rosch PJ; Sutter MC
    JAMA; 2006 Jun; 295(21):2476; author reply 2478-9. PubMed ID: 16757714
    [No Abstract]   [Full Text] [Related]  

  • 3. High-dose statins and the IDEAL study.
    Ong HT; Cheah JS
    JAMA; 2006 Jun; 295(21):2476-7; author reply 2478-9. PubMed ID: 16757712
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk factors for rhabdomyolysis with simvastatin and atorvastatin.
    Golomb B; Evans M
    Drug Saf; 2006; 29(12):1191; author reply 1191-2. PubMed ID: 17147465
    [No Abstract]   [Full Text] [Related]  

  • 5. Paradoxical decrease in serum high-density lipoprotein cholesterol and lipid-lowering drugs.
    Crook MA
    Ann Clin Biochem; 2011 Jan; 48(Pt 1):3-4. PubMed ID: 21273636
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of tachyphylaxis on statin treatment.
    Miserez AR; Keller U; Mirsaidi R
    Am J Cardiol; 2001 Oct; 88(8):936-7. PubMed ID: 11676971
    [No Abstract]   [Full Text] [Related]  

  • 7. Spontaneous reports cannot serve as a basis for comparison of two drugs.
    Jones JK
    Am J Cardiol; 2003 Nov; 92(9):1141-2. PubMed ID: 14583380
    [No Abstract]   [Full Text] [Related]  

  • 8. Cognitive impairment associated with atorvastatin and simvastatin.
    King DS; Wilburn AJ; Wofford MR; Harrell TK; Lindley BJ; Jones DW
    Pharmacotherapy; 2003 Dec; 23(12):1663-7. PubMed ID: 14695047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose statins and the IDEAL study.
    Mann SJ
    JAMA; 2006 Jun; 295(21):2477-8; author reply 2478-9. PubMed ID: 16757715
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety of high-dose atorvastatin therapy.
    Waters DD
    Am J Cardiol; 2005 Sep; 96(5A):69F-75F. PubMed ID: 16126026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New light on statin side effects. What recent research on the cholesterol drugs means to you.
    Heart Advis; 2005 Aug; 8(8):3. PubMed ID: 16193557
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of the frequency of adverse events in patients treated with atorvastatin or simvastatin.
    Abourjaily HM; Alsheikh-Ali AA; Karas RH
    Am J Cardiol; 2003 Apr; 91(8):999-1002, A7. PubMed ID: 12686348
    [No Abstract]   [Full Text] [Related]  

  • 13. Comment and reply on: Atorvastatin: safety and tolerability. Statins and polymyositis: a neglected link?
    Famularo G; Minisola G; Gasbarrone L
    Expert Opin Drug Saf; 2010 Nov; 9(6):1005-6; author reply 1006. PubMed ID: 20919802
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk factors for rhabdomyolysis with simvastatin and atorvastatin.
    Ronaldson KJ; O'Shea JM; Boyd IW
    Drug Saf; 2006; 29(11):1061-7. PubMed ID: 17061911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
    Paradis JM; LeLorier J
    N Engl J Med; 2004 Aug; 351(7):714-7; author reply 714-7. PubMed ID: 15309744
    [No Abstract]   [Full Text] [Related]  

  • 16. [Interaction risk with statin switch].
    Molden E; Westergren T
    Tidsskr Nor Laegeforen; 2007 Feb; 127(4):428-31. PubMed ID: 17304269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causal structures for evaluating statin class effects.
    Seeger JD
    Ann Pharmacother; 2002 Dec; 36(12):1961-5. PubMed ID: 12494951
    [No Abstract]   [Full Text] [Related]  

  • 18. The HMG Co-A reductase inhibitors ('statins') and myotoxic effects.
    S Afr Med J; 2002 Aug; 92(8):596-7. PubMed ID: 12244613
    [No Abstract]   [Full Text] [Related]  

  • 19. Statin drugs and congenital anomalies.
    Gibb H; Scialli AR
    Am J Med Genet A; 2005 Jun; 135(2):230-1; author reply 232-4. PubMed ID: 15810007
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin.
    Brunham LR; Lansberg PJ; Zhang L; Miao F; Carter C; Hovingh GK; Visscher H; Jukema JW; Stalenhoef AF; Ross CJ; Carleton BC; Kastelein JJ; Hayden MR
    Pharmacogenomics J; 2012 Jun; 12(3):233-7. PubMed ID: 21243006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.